Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “IRONWOOD PHARMACEUTICALS, INC.”

45 pharma patents match "IRONWOOD PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 45
Index total 30,257
Page 1 / 2

Quick answer

This filtered view shows 45 pharmaceutical patents matching "IRONWOOD PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

45 results for “IRONWOOD PHARMACEUTICALS, INC.” · 30,257 patents in full index Clear search

  1. US 10702576

    Stable formulations of linaclotide

    IRONWOOD PHARMACEUTICALS, INC. · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted

  2. US 10675325

    Stable formulations of linaclotide

    IRONWOOD PHARMACEUTICALS, INC. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted

  3. US 10618938

    Compositions for colon cleansing and the treatment of gastrointestinal disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted

  4. US 10266529

    Salts, co-crystals, and polymorphs of an anxiolytic compound

    IRONWOOD PHARMACEUTICALS, INC. · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  5. US 10189809

    SGC stimulators

    IRONWOOD PHARMACEUTICALS, INC. · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted

  6. US 10183021

    sGC stimulators

    IRONWOOD PHARMACEUTICALS, INC. · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  7. US 10047095

    sGC stimulators

    IRONWOOD PHARMACEUTICALS, INC. · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted

  8. US 9969742

    Imidazotriazinone compounds

    IRONWOOD PHARMACEUTICALS, INC. · Granted May 15, 2018 · Expires May 10, 2038

    granted

  9. US 9840536

    Methods and compositions for the treatment of gastrointestinal disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted

  10. US 9745296

    Salts, co-crystals, and polymorphs of an anxiolytic compound

    IRONWOOD PHARMACEUTICALS, INC. · Granted Aug 29, 2017 · Expires Aug 24, 2037

    granted

  11. US 9725453

    Imidazotriazinone compounds

    IRONWOOD PHARMACEUTICALS, INC. · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted

  12. US 9708371

    Treatments for gastrointestinal disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  13. US 9657012

    FAAH inhibitors

    IRONWOOD PHARMACEUTICALS, INC. · Granted May 23, 2017 · Expires May 18, 2037

    granted

  14. US 9650417

    Treatments for gastrointestinal disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted May 16, 2017 · Expires May 11, 2037

    granted

  15. US 9617305

    Treatments for gastrointestinal disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  16. US 9586937

    sGC stimulators

    IRONWOOD PHARMACEUTICALS, INC. · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted

  17. US 9540380

    Imidazotriazinone compounds

    IRONWOOD PHARMACEUTICALS, INC. · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  18. US 9527887

    Treatments for gastrointestinal disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted Dec 27, 2016 · Expires Dec 22, 2036

    granted

  19. US 9487508

    SGC stimulators

    IRONWOOD PHARMACEUTICALS, INC. · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted

  20. US 9481689

    sGC stimulators

    IRONWOOD PHARMACEUTICALS, INC. · Granted Nov 1, 2016 · Expires Oct 27, 2036

    granted

  21. US 9309235

    SGC stimulators

    IRONWOOD PHARMACEUTICALS, INC. · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  22. US 9303066

    Treatments for gastrointestinal disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted

  23. US 9205094

    Compositions comprising bile acid sequestrants for treating esophageal disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted Dec 8, 2015 · Expires Dec 3, 2035

    granted

  24. US 9139564

    2-benzyl, 3-(pyrimidin-2-yl) substituted pyrazoles useful as sGC stimulators

    IRONWOOD PHARMACEUTICALS, INC. · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.